Search Results - Paolo Ghia
- Showing 1 - 20 results of 100
- Go to Next Page
-
1
Modeling the Leukemia Microenviroment In Vitro by Cristina Scielzo, Paolo Ghia, Paolo Ghia, Paolo Ghia
Published 2020-12-01
Article -
2
Another piece of the puzzle: is there a “nodal” monoclonal B-cell lymphocytosis? by Paolo Ghia
Published 2011-08-01
Article -
3
From Mice to Men: How B Cell Immunology Helped the Understanding of Leukemia Development by Paolo Ghia
Published 2018-10-01
Article -
4
Management of chronic lymphocytic leukemia by Paolo Ghia, Michael Hallek
Published 2014-06-01
Article -
5
Ibrutinib in the real world patient: many lights and some shades by Paolo Ghia, Antonio Cuneo
Published 2016-12-01
Article -
6
-
7
-
8
-
9
-
10
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells by Francesca Vittoria Sbrana, Riccardo Pinos, Riccardo Pinos, Federica Barbaglio, Davide Ribezzi, Davide Ribezzi, Fiorella Scagnoli, Lydia Scarfò, Lydia Scarfò, Itedale Namro Redwan, Hector Martinez, Silvia Farè, Paolo Ghia, Paolo Ghia, Cristina Scielzo
Published 2021-05-01
Article -
11
What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment by Luca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, Stefano Molica, Patrizio Pasqualetti, Lydia Scarfò, Paolo Ghia
Published 2022-09-01
Article -
12
-
13
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine by Roberta Valsecchi, Nadia Coltella, Daniela Magliulo, Lucia Bongiovanni, Lydia Scarfò, Paolo Ghia, Maurilio Ponzoni, Rosa Bernardi
Published 2020-05-01
Article -
14
-
15
Challenges and Solutions for Collecting and Analyzing Real World Data: The Eric CLL Database as an Illustrative Example by Anastasia Chatzidimitriou, Eva Minga, Thomas Chatzikonstantinou, Carol Moreno, Kostas Stamatopoulos, Paolo Ghia, on behalf of ERIC, the European Research Initiative on CLL
Published 2020-10-01
Article -
16
-
17
P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA by Alan Skarbnik, Adam Kittai, Miguel Miranda, Alan Yong, Jack Roos, Robert Hettle, Sarah Palazuelos-Munoz, Vikram Shetty, Paolo Ghia
Published 2023-08-01
Article -
18
P643: CUMULATIVE REVIEW OF HEART FAILURE WITH ACALABRUTINIB IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA USING DATA FROM CLINICAL TRIALS AND POST-MARKETING EXPERIENCE by Paolo Ghia, Manan Pareek, Shogheeg Apkarian Bourjlian, Naghmana Bajwa, Anthony J. Corry, Suman Jannuru, Georg Kreuzbauer, Husam Abdel-Qadir
Published 2023-08-01
Article -
19
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis by Paolo Ghia, Heiko Bruns, Martin Böttcher, Junyan Lu, Elisavet Chartomatsidou, Nikos Papakonstantinou, Kristin Mentz, Thorsten Zenz, Marco Herling, Wolfgang Huber
Published 2021-04-01
Article -
20
Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond by Richard Rosenquist, Andreas Rosenwald, Ming-Qing Du, Gianluca Gaidano, Patricia Groenen, Andrew Wotherspoon, Paolo Ghia, Philippe Gaulard, Elias Campo, Kostas Stamatopoulos
Published 2016-09-01
Article